Identification of tetracenomycin X from a marine-derived Saccharothrix sp. guided by genes sequence analysis

Yaoxue Xuebao

Volumn 49, Issue 2, 2014, Pages 230-236

  Liu, Bin ^a,c   Tan, Yi ^a   Gan, Mao Luo ^a,b   Zhou, Hong Xia ^a   Wang, Yi Guang ^a   Ping, Yu Hui ^c   Li, Bin ^c   Yang, Zhao Yong ^a   Xiao, Chun Ling ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Antibiotic resistance; Genomic mining; Marine derived actinomycete; Oxotomaymycin; Saccharothrix sp.; Tetracenomycin X

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; OXOTOMAYMYCIN; TETRACENOMYCIN X; UNCLASSIFIED DRUG; BENZODIAZEPINE DERIVATIVE; NAPHTHACENE DERIVATIVE;

ACTINOBACTERIA; ANTIBACTERIAL ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG CYTOTOXICITY; DRUG IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; HEPG2 CELL LINE; HL 60 CELL LINE; HUMAN; HUMAN CELL; IC 50; MCF 7 CELL LINE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SACCHAROTHRIX; VANCOMYCIN RESISTANT ENTEROCOCCUS; ACTINOMYCETALES; ANTIBIOTIC RESISTANCE; CHEMICAL STRUCTURE; CHEMISTRY; DATA MINING; DRUG EFFECTS; ENTEROCOCCUS FAECALIS; FERMENTATION; GENETICS; GENOMICS; IC50; ISOLATION AND PURIFICATION; MARINE BIOLOGY; MICROBIAL SENSITIVITY TEST; PHYLOGENY; PROCEDURES; STAPHYLOCOCCUS EPIDERMIDIS; TUMOR CELL LINE;

ACTINOMYCETALES; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BENZODIAZEPINONES; CELL LINE, TUMOR; DATA MINING; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; FERMENTATION; GENOMICS; HUMANS; INHIBITORY CONCENTRATION 50; MARINE BIOLOGY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NAPHTHACENES; PHYLOGENY; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84899567150     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Theuretzbacher U. Accelerating resistance, inadequate antibacterial drug pipelines and international responses [J]. Int J Antimicrob Agents, 2012, 39: 295-299.
2. Walsh CT, Wencewicz TA. Prospects for new antibiotics: a molecule-centered perspective [J]. J Antibiot, 2013, http://dx.doi.org/10.1038/ ja.2013.49.
3. Berdy J. Thoughts and facts about antibiotics: where we are now and where we are heading [J]. J Antibiot, 2012, 65: 385-395.
4. Fenical W, Jensen PR. Developing a new resource for drug discovery: marine actinomycete bacteria [J]. Nat Chem Biol, 2006, 2: 666-673. (Pubitemid 44764208)
5. Rahman H, Austin B, Mitchell W, et al. Novel anti-infective compounds from marine bacteria [J]. Mar Drugs, 2010, 8: 498-518.
6. Olano C, Méndez C, Salas JA. Gene clusters for bioactive natural products in actinomycetes and their use in combinatorial biosynthesis [M] // Dyson P editor. Streptomyces Molecular Biology and Biotechnology. Norfolk: Caister Academic Press, 2011.
7. Liu W, Ahlert J, Gao Q, et al. Rapid PCR amplification of minimal enediyne polyketide synthase cassettes leads to a predictive familial classification model [J]. Proc Natl Acad Sci USA, 2003, 100: 11959-11963. (Pubitemid 37271497)
8. Hornung A, Bertazzo M, Dziarnowski A, et al. A genomic screening approach to the structure-guided identification of drug candidates from natural sources [J]. ChemBioChem, 2007, 8: 757-766. (Pubitemid 47183632)
9. Chen F, Lin L, Wang L, et al. Distribution of dTDP-glucose-4,6- dehydratase gene and diversity of potential glycosylated natural products in marine sediment-derived bacteria [J]. Appl Microbiol Biotechnol, 2011, 90: 1347-1359.
10. Rateb ME, Houssen WE, Arnold M, et al. Chaxamycins A -D, bioactive ansamycins from a hyper-arid desert Streptomyces sp. [J]. J Nat Prod, 2011, 74: 1491-1499.
11. Zhang W, Liu Z, Li S, et al. Spiroindimicins A -D: new bisindole alkaloids from a deep-sea-derived actinomycete [J]. Org Lett, 2012, 14: 3364-3367.
12. Gan ML, Zheng XD, Gan LS, et al. Streptothricin derivatives from Streptomyces sp. I08A 1776 [J]. J Nat Prod, 2011, 74: 1142-1147.
13. Gan ML, Guan Y, Zheng XD, et al. Two streptothricins with a cis-streptolidine lactam moiety from Streptomyces sp. I08A 1776 [J]. J Antibiot, 2012, 65: 513-516.
14. Gan ML, Liu YF, Bai YL, et al. Polyketides with New Delhi metallo-β-lactamase 1 inhibitory activity from Penicillium sp. [J]. J Nat Prod, 2013, 76: 1535-1540.
15. Zhang HT, Wu LZ, Liu AM, et al. PCR screening of 3-amino-5-hydroxybenzoic acid synthase gene leads to identification of ansamycins and AHBA-related antibiotic producers in actinomycetes [J]. J Appl Microbiol, 2009, 106: 755-763.
16. Ayuso-Sacido A, Genilloud O. New PCR primers for the screening of NRPS and PKS-I systems in actinomycetes: detection and distribution of these biosynthetic gene sequences in major taxonomic groups [J]. Microb Ecol, 2005, 49: 10-24. (Pubitemid 40747800)
17. Metsa-Ketela M, Salo V, Halo L, et al. An efficient approach for screening minimal PKS genes from Streptomyces [J]. FEMS Microbiol Lett, 1999, 180: 1-6. (Pubitemid 29476486)
18. Wang H, Liu N, Xi L, et al. Genetic screening strategy for rapid access to polyether ionophore producers and products in actinomycetes [J]. Appl Environ Microbiol, 2011, 77: 3433-3442.
19. Bibb MJ, Biro S, Motamedi H, et al. Analysis of the nucleotide sequence of the Streptomyces glaucescens tcmI genes provides key information about the enzymology of polyketide antibiotic biosynthesis [J]. EMBO J, 1989, 8: 2727-2736. (Pubitemid 19273359)
20. Ramos A, Lombo F, Brana AF, et al. Biosynthesis of elloramycin in Streptomyces olivaceus requires glycosylation by enzymes encoded outside the aglycon cluster [J]. Microbiology, 2008, 154: 781-788. (Pubitemid 351736292)
21. Decker H, Haag S, Udvarnoki G, et al. Novel genetically engineered tetracenomycins [J]. Angew Chem Int Ed, 1995, 34: 1107-1110.
22. Rohr J, Zeeck A. Structure-activity relationships of elloramycin and tetracenomycin C [J]. J Antibiot, 1990, 43: 1169-1178. (Pubitemid 20324380)
23. Wohlert SE, Blanco G, Lombó F, et al. Novel hybrid tetracenomycins through combinatorial biosynthesis using a glycosyltransferase encoded by the elm genes in cosmid 16F4 and which shows a broad sugar substrate specificity [J]. J Am Chem Soc, 1998, 120: 10596-10601. (Pubitemid 28498802)
24. Anderson MG, Khoo CL, Rickards RW. Oxidation processes in the biosynthesis of the tetracenomycin and elloramycin antibiotics [J]. J Antibiot, 1989, 42: 640-643. (Pubitemid 19119110)
25. Tozuka Z, Takaya T. Studies on tomaymycin. I. The structure determination of tomaymycin on the basis of NMR spectra [J]. J Antibiot, 1983, 36: 142-146. (Pubitemid 13148120)
26. Kariyone K, Yazawa H, Kohsaka M. The sructure of tomaymycin and oxotomamycin [J]. Chem Pharm Bull, 1971, 11: 2289-2293.
27. Weber W, Zähner H, Siebers J, et al. Metabolic products of microorganisms. 175. Tetracenomycin C [J]. Arch Microbiol, 1979, 121: 111-116. (Pubitemid 9233775)
28. Weber W, Zahner H, Siebers J, et al. Tetracenomycins - new antibiotics from Streptomyces glaucescens [C] // Schaal, K. P. and Pulverer, G (eds.). Actinomycetes: Proceedings of the Fourth International Symposium on Actinomycete Biology. Stuttgart: Gustav Fischer Verlag, 1981: 465-468.
29. Drautz H, Reuschenbach P, Zahner H, et al. Metabolic products of microorganisms. 225. Elloramycin, a new anthracycline-like antibiotic from Streptomyces olivaceus. Isolation, characterization, structure and biological properties [J]. J Antibiot, 1985, 38: 1291-1301. (Pubitemid 16206700)
30. Khosla C, Gokhale RS, Jacobsen JR, et al. Tolerance and specificity of polyketide synthases [J]. Annu Rev Biochem, 1999, 68: 219-253. (Pubitemid 29449192)
31. Clinical Laboratory Standards Institute (CLSI). Methods for Dilution Antimcrobial Susceptibility Tests for Bacteria that Grow Aerobically [S]. 8th ed. Wayne, USA: CLSI. 2009.